Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis.
作者： Sasan Roayaie , Jonathan D. Schwartz , Max W. Sung , Sukru H. Emre , Charles M. Miller
DOI: 10.1002/LT.20128
关键词:
摘要: … recurrence of hepatocellular carcinoma (… recurrence were included in further analysis. The endpoints analyzed were survival from time of transplant and survival from time of recurrence. …
sci-hub.se 参考文章(14)
Okada S, Chemotherapy in hepatocellular carcinoma. Hepato-gastroenterology. ,vol. 45, pp. 1259- 1263 ,(1998)
Ching‐Lung Lai, Anna Suk‐Fong Lok, Pui‐Chee Wu, Gerald Chee‐Bunn Chan, Hsiang‐Ju Lin, None, Doxorubicin versus no antitumor therapy in inoperable hepatocellular carcinoma. A prospective randomized trial. Cancer. ,vol. 62, pp. 479- 483 ,(1988) , 10.1002/1097-0142(19880801)62:3<479::AID-CNCR2820620306>3.0.CO;2-L
Goran B. Klintmalm, Liver Transplantation for Hepatocellular Carcinoma Annals of Surgery. ,vol. 228, pp. 479- 490 ,(1998) , 10.1097/00000658-199810000-00005
Enrico Regalia, Luigi Rainero Fassati, Umberto Valente, Andrea Pulvirenti, Isabella Damilano, Giovanni Dardano, Fabrizio Montalto, Jorgelina Coppa, Vincenzo Mazzaferro, Pattern and management of recurrent hepatocellular carcinoma after liver transplantation Journal of Hepato-biliary-pancreatic Surgery. ,vol. 5, pp. 29- 34 ,(1998) , 10.1007/PL00009947
Lee S. Rosen, Efficacy and safety of zoledronic acid in the treatment of bone metastases associated with lung cancer and other solid tumors. Seminars in Oncology. ,vol. 29, pp. 28- 32 ,(2002) , 10.1053/SONC.2002.37416
Francis Y Yao, Linda Ferrell, Nathan M Bass, Jessica J Watson, Peter Bacchetti, Alan Venook, Nancy L Ascher, John P Roberts, Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival Hepatology. ,vol. 33, pp. 1394- 1403 ,(2001) , 10.1053/JHEP.2001.24563
Young-Hwa Chung, Il Han Song, Byung-Cheol Song, Geun Chan Lee, Moon Soo Koh, Hyum-Ki Yoon, Yung Sang Lee, Kyu-Bo Sung, Dong Jin Suh, Combined therapy consisting of intraarterial cisplatin infusion and systemic interferon‐α for hepatocellular carcinoma patients with major portal vein thrombosis or distant metastasis Cancer. ,vol. 88, pp. 1986- 1991 ,(2000) , 10.1002/(SICI)1097-0142(20000501)88:9<1986::AID-CNCR2>3.0.CO;2-I
Chung-Mau Lo, Henry Ngan, Wai-Kuen Tso, Chi-Leung Liu, Chi-Ming Lam, Ronnie Tung-Ping Poon, Sheung-Tat Fan, John Wong, Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology. ,vol. 35, pp. 1164- 1171 ,(2002) , 10.1053/JHEP.2002.33156
Toru Ishikawa, Takafumi Ichida, Soichi Sugitani, Yasunori Tsuboi, Takuya Genda, Satoshi Sugahara, Kazuhiro Uehara, Jun Inayoshi, Junji Yokoyama, Yuiko Ishimoto, Hitoshi Asakura, Improved survival with oral administration of enteric-coated tegafur/uracil for advanced stage IV-A hepatocellular carcinoma. Journal of Gastroenterology and Hepatology. ,vol. 16, pp. 452- 459 ,(2001) , 10.1046/J.1440-1746.2001.02352.X
Tomoki Nakajima, Michihisa Moriguchi, Yasuhide Mitsumoto, Tatsuo Katagishi, Hiroyuki Kimura, Hiroyuki Shintani, Takeshi Deguchi, Takeshi Okanoue, Keizo Kagawa, Tsukasa Ashihara, Simple tumor profile chart based on cell kinetic parameters and histologic grade is useful for estimating the natural growth rate of hepatocellular carcinoma Human Pathology. ,vol. 33, pp. 92- 99 ,(2002) , 10.1053/HUPA.2002.30194